MacroGenics Inc (MGNX) stock
MGNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.05−0.12 (-5.53%)
Close on Nov 17, 2026Market cap $130.59MP/E –Yield –
MacroGenics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
MacroGenics's operating cash flow for the twelve months ending Jun 30, 2026 was -$63.72M. For fiscal 2025 it was -$81.04M. The highest annual figure on record is $14.41M in fiscal 2017.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$81.04M | – |
| FY2024 | Dec 31, 2024 | -$68.37M | – |
| FY2023 | Dec 31, 2023 | -$78.21M | – |
| FY2022 | Dec 31, 2022 | -$86.96M | – |
| FY2021 | Dec 31, 2021 | -$143.83M | – |
| FY2020 | Dec 31, 2020 | -$111.90M | – |
| FY2019 | Dec 31, 2019 | -$134.27M | – |
| FY2018 | Dec 31, 2018 | -$153.23M | -1163.8% |
| FY2017 | Dec 31, 2017 | $14.41M | – |
| FY2016 | Dec 31, 2016 | -$43.68M | – |
| FY2015 | Dec 31, 2015 | -$13.66M | – |
| FY2014 | Dec 31, 2014 | -$32.76M | – |
| FY2013 | Dec 31, 2013 | -$14.17M | – |
| FY2012 | Dec 31, 2012 | -$6.58M | -197.4% |
| FY2011 | Dec 31, 2011 | $6.76M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$40.75M | – |
| Q1 FY2026 | Mar 31, 2026 | -$35.81M | – |
| Q4 FY2025 | Dec 31, 2025 | $43.02M | – |
| Q3 FY2025 | Sep 30, 2025 | -$30.19M | -150.2% |
| Q2 FY2025 | Jun 30, 2025 | -$46.99M | – |
| Q1 FY2025 | Mar 31, 2025 | -$46.89M | – |
| Q4 FY2024 | Dec 31, 2024 | -$38.41M | – |
| Q3 FY2024 | Sep 30, 2024 | $60.16M | – |
| Q2 FY2024 | Jun 30, 2024 | -$44.49M | – |
| Q1 FY2024 | Mar 31, 2024 | -$45.64M | – |
| Q4 FY2023 | Dec 31, 2023 | -$28.04M | -195.6% |
| Q3 FY2023 | Sep 30, 2023 | -$35.25M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.09M | – |
| Q1 FY2023 | Mar 31, 2023 | -$12.83M | – |
| Q4 FY2022 | Dec 31, 2022 | $29.32M | – |
| Q3 FY2022 | Sep 30, 2022 | -$9.42M | – |
| Q2 FY2022 | Jun 30, 2022 | -$49.16M | – |
| Q1 FY2022 | Mar 31, 2022 | -$57.70M | – |
| Q4 FY2021 | Dec 31, 2021 | -$54.31M | – |
| Q3 FY2021 | Sep 30, 2021 | -$14.80M | – |
| Q2 FY2021 | Jun 30, 2021 | -$45.69M | – |
| Q1 FY2021 | Mar 31, 2021 | -$29.04M | – |
| Q4 FY2020 | Dec 31, 2020 | -$5.53M | – |
| Q3 FY2020 | Sep 30, 2020 | -$25.68M | – |
| Q2 FY2020 | Jun 30, 2020 | -$36.55M | – |
| Q1 FY2020 | Mar 31, 2020 | -$44.14M | – |
| Q4 FY2019 | Dec 31, 2019 | -$38.04M | – |
| Q3 FY2019 | Sep 30, 2019 | -$17.39M | – |
| Q2 FY2019 | Jun 30, 2019 | -$48.84M | – |
| Q1 FY2019 | Mar 31, 2019 | -$30.00M | – |
| Q4 FY2018 | Dec 31, 2018 | -$27.23M | -124.3% |
| Q3 FY2018 | Sep 30, 2018 | -$36.98M | – |
| Q2 FY2018 | Jun 30, 2018 | -$57.73M | – |
| Q1 FY2018 | Mar 31, 2018 | -$31.30M | – |
| Q4 FY2017 | Dec 31, 2017 | $111.85M | – |
| Q3 FY2017 | Sep 30, 2017 | -$31.35M | -163.0% |
| Q2 FY2017 | Jun 30, 2017 | -$30.76M | – |
| Q1 FY2017 | Mar 31, 2017 | -$35.33M | – |
| Q4 FY2016 | Dec 31, 2016 | -$28.33M | – |
| Q3 FY2016 | Sep 30, 2016 | $49.79M | – |
See a number that looks wrong?